Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACOR

Acorda Therapeutics (ACOR)

Acorda Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACOR
DateTimeSourceHeadlineSymbolCompany
16/04/202407:03Business WireAcorda Therapeutics Announces Delisting from NasdaqNASDAQ:ACORAcorda Therapeutics Inc
04/04/202408:30Business WireAcorda Therapeutics Announces Nasdaq Delisting NotificationNASDAQ:ACORAcorda Therapeutics Inc
02/04/202409:35Business WireAcorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase AgreementNASDAQ:ACORAcorda Therapeutics Inc
02/04/202407:01Business WireAcorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024NASDAQ:ACORAcorda Therapeutics Inc
26/03/202407:01Business WireAcorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024NASDAQ:ACORAcorda Therapeutics Inc
12/01/202400:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
12/01/202400:01Business WireAcorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025NASDAQ:ACORAcorda Therapeutics Inc
02/12/202308:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
14/11/202308:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
14/11/202308:01Business WireAcorda Therapeutics Reports Third Quarter 2023 Financial ResultsNASDAQ:ACORAcorda Therapeutics Inc
07/11/202308:01Business WireAcorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023NASDAQ:ACORAcorda Therapeutics Inc
07/11/202300:00Business WireAcorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®NASDAQ:ACORAcorda Therapeutics Inc
09/08/202306:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
09/08/202306:01Business WireAcorda Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:ACORAcorda Therapeutics Inc
02/08/202322:00Business WireAcorda Therapeutics Announces Launch of New INBRIJA® Campaign: “For The Fighters™”NASDAQ:ACORAcorda Therapeutics Inc
01/08/202322:00Business WireAcorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023NASDAQ:ACORAcorda Therapeutics Inc
29/06/202307:08Business WireTom Burns Elected to the Acorda Therapeutics Board of DirectorsNASDAQ:ACORAcorda Therapeutics Inc
27/06/202306:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
26/06/202322:23Business WireAcorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ACORAcorda Therapeutics Inc
26/06/202322:00Business WireAcorda Therapeutics Regains Compliance with Nadaq Minimum Bid Price RequirementNASDAQ:ACORAcorda Therapeutics Inc
24/06/202307:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
24/06/202307:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
24/06/202307:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
24/06/202307:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
03/06/202306:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
03/06/202306:01Business WireAcorda Therapeutics Announces Completion of 1-for-20 Reverse Stock SplitNASDAQ:ACORAcorda Therapeutics Inc
02/06/202307:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
01/06/202307:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
01/06/202306:01Business WireAcorda Therapeutics to Conduct 1-for-20 Reverse Stock SplitNASDAQ:ACORAcorda Therapeutics Inc
30/05/202322:00Business WireAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&ANASDAQ:ACORAcorda Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ACOR